⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
RZLT News
Rezolute, Inc. Common Stock (NV)
Rezolute Announces Oral Presentation of Results From its Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism at the Pediatric Endocrine Society Annual Meeting
globenewswire.com
RZLT
Rezolute, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
RZLT
Rezolute to Present Results from its Phase 3 sunRIZE Study in Congenital Hyperinsulinism at the Pediatric Endocrine Society (PES) Annual Meeting
globenewswire.com
RZLT
Form 8-K
sec.gov
RZLT
Rezolute Provides Update on its Congenital Hyperinsulinism Program Following FDA Meeting
globenewswire.com
RZLT
RZLT INVESTOR ALERT: Faruqi & Faruqi, LLP Launches Investigation into Rezolute
businesswire.com
RZLT
INVESTIGATION NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute (RZLT)
prnewswire.com
RZLT
Rezolute to Participate in the Citizens Life Sciences Conference
globenewswire.com
RZLT
RZLT SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
globenewswire.com
RZLT
RZLT INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rezolute
prnewswire.com
RZLT